118 related articles for article (PubMed ID: 38272773)
1. Multiparametric MRI model to predict molecular subtypes of breast cancer using Shapley additive explanations interpretability analysis.
Huang Y; Wang X; Cao Y; Li M; Li L; Chen H; Tang S; Lan X; Jiang F; Zhang J
Diagn Interv Imaging; 2024 May; 105(5):191-205. PubMed ID: 38272773
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer molecular subtype prediction: Improving interpretability of complex machine-learning models based on multiparametric-MRI features using SHapley Additive exPlanations (SHAP) methodology.
Crombé A; Kataoka M
Diagn Interv Imaging; 2024 May; 105(5):161-162. PubMed ID: 38365542
[No Abstract] [Full Text] [Related]
3. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
[TBL] [Abstract][Full Text] [Related]
4. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive assessment of breast cancer molecular subtypes on multiparametric MRI using convolutional neural network with transfer learning.
Yin H; Bai L; Jia H; Lin G
Thorac Cancer; 2022 Nov; 13(22):3183-3191. PubMed ID: 36203226
[TBL] [Abstract][Full Text] [Related]
6. Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms.
Ma M; Liu R; Wen C; Xu W; Xu Z; Wang S; Wu J; Pan D; Zheng B; Qin G; Chen W
Eur Radiol; 2022 Mar; 32(3):1652-1662. PubMed ID: 34647174
[TBL] [Abstract][Full Text] [Related]
7. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
[TBL] [Abstract][Full Text] [Related]
8. Machine learning with multiparametric breast MRI for prediction of Ki-67 and histologic grade in early-stage luminal breast cancer.
Song SE; Cho KR; Cho Y; Kim K; Jung SP; Seo BK; Woo OH
Eur Radiol; 2022 Feb; 32(2):853-863. PubMed ID: 34383145
[TBL] [Abstract][Full Text] [Related]
9. Invasive ductal breast cancer molecular subtype prediction by MRI radiomic and clinical features based on machine learning.
Sheng W; Xia S; Wang Y; Yan L; Ke S; Mellisa E; Gong F; Zheng Y; Tang T
Front Oncol; 2022; 12():964605. PubMed ID: 36172153
[TBL] [Abstract][Full Text] [Related]
10. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Prognostic Factors and Genotypes in Patients With Breast Cancer Using Multiple Mathematical Models of MR Diffusion Imaging.
Wang W; Zhang X; Zhu L; Chen Y; Dou W; Zhao F; Zhou Z; Sun Z
Front Oncol; 2022; 12():825264. PubMed ID: 35174093
[TBL] [Abstract][Full Text] [Related]
14. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
[TBL] [Abstract][Full Text] [Related]
15. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI.
Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X
J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517
[TBL] [Abstract][Full Text] [Related]
16. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
[TBL] [Abstract][Full Text] [Related]
17. Use of Pretreatment Multiparametric MRI to Predict Tumor Regression Pattern to Neoadjuvant Chemotherapy in Breast Cancer.
Liu C; Huang X; Chen X; Shi Z; Liu C; Liang Y; Huang X; Chen M; Chen X; Liang C; Liu Z
Acad Radiol; 2023 Sep; 30 Suppl 2():S62-S70. PubMed ID: 37019697
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the Nottingham prognostic index and molecular subtypes of breast cancer through multimodal magnetic resonance imaging.
Chen K; Yu C; Pan J; Xu Y; Luo Y; Yang T; Yang X; Xie L; Zhang J; Zhuo R
Magn Reson Imaging; 2024 May; 108():168-175. PubMed ID: 38408689
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers.
Ramtohul T; Djerroudi L; Lissavalid E; Nhy C; Redon L; Ikni L; Djelouah M; Journo G; Menet E; Cabel L; Malhaire C; Tardivon A
Radiology; 2023 Aug; 308(2):e222646. PubMed ID: 37526540
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
Eur Radiol; 2024 Feb; ():. PubMed ID: 38363315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
